Dr. Pelosof is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-3976Fax+1 202-444-5104
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2007 - 2010
- Washington University in St. Louis School of MedicineClass of 2007
Certifications & Licensure
- TX State Medical License 2010 - 2026
- DC State Medical License 2017 - 2024
- MD State Medical License 2010 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- 201 citationsA 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review.Julia A. Beaver, Lynn J. Howie, Lorraine Pelosof, Kim Ts, Jinzhong Liu
JAMA Oncology. 2018-06-01 - 25 citationsOncologic emergencies and urgencies: A comprehensive review.Bonnie E Gould Rothberg, Tammie E Quest, Sai-Ching J Yeung, Lorraine C Pelosof, David E Gerber
CA. 2022-11-01 - 53 citationsSystematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, Yutao Gong, Kirsten B. Goldberg
The Oncologist. 2021-10-01
Press Mentions
- Nonsmokers Account for Rising Proportion of Lung Cancer Cases, Studies FindSeptember 10th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: